Literature DB >> 18644887

The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion.

Rogier Louwen1, Astrid Heikema, Alex van Belkum, Alewijn Ott, Michel Gilbert, Wim Ang, Hubert P Endtz, Mathijs P Bergman, Edward E Nieuwenhuis.   

Abstract

Campylobacter jejuni is a frequent cause of bacterial gastroenteritis worldwide. Lipooligosaccharide (LOS) has been identified as an important virulence factor that may play a role in microbial adhesion and invasion. Here we specifically address the question of whether LOS sialylation affects the interaction of C. jejuni with human epithelial cells. For this purpose, 14 strains associated with Guillain-Barré syndrome (GBS), 34 enteritis-associated strains, the 81-176 reference strain, and 6 Penner serotype strains were tested for invasion of two epithelial cell lines. C. jejuni strains expressing sialylated LOS (classes A, B, and C) invaded cells significantly more frequently than strains expressing nonsialylated LOS (classes D and E) (P < 0.0001). To further explore this observation, we inactivated the LOS sialyltransferase (Cst-II) via knockout mutagenesis in three GBS-associated C. jejuni strains expressing sialylated LOS (GB2, GB11, and GB19). All knockout strains displayed significantly lower levels of invasion than the respective wild types. Complementation of a Deltacst-II mutant strain restored LOS sialylation and reset the invasiveness to wild-type levels. Finally, formalin-fixed wild-type strains GB2, GB11 and GB19, but not the isogenic Deltacst-II mutants that lack sialic acid, were able to inhibit epithelial invasion by viable GB2, GB11, and GB19 strains. We conclude that sialylation of the LOS outer core contributes significantly to epithelial invasion by C. jejuni and may thus play a role in subsequent postinfectious pathologies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18644887      PMCID: PMC2546812          DOI: 10.1128/IAI.00321-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Identification and molecular cloning of a gene encoding a fibronectin-binding protein (CadF) from Campylobacter jejuni.

Authors:  M E Konkel; S G Garvis; S L Tipton; D E Anderson; W Cieplak
Journal:  Mol Microbiol       Date:  1997-06       Impact factor: 3.501

2.  Lipo-oligosaccharides of Campylobacter jejuni serotype O:10. Structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher syndrome and from the serotype reference strain.

Authors:  J E Shin; S Ackloo; A S Mainkar; M A Monteiro; H Pang; J L Penner; G O Aspinall
Journal:  Carbohydr Res       Date:  1997-12       Impact factor: 2.104

Review 3.  Pathogenesis of enteric infection by Campylobacter.

Authors:  Julian M Ketley
Journal:  Microbiology (Reading)       Date:  1997-01       Impact factor: 2.777

4.  Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice.

Authors:  Z Pei; C Burucoa; B Grignon; S Baqar; X Z Huang; D J Kopecko; A L Bourgeois; J L Fauchere; M J Blaser
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

5.  Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide.

Authors:  G O Aspinall; A G McDonald; T S Raju; H Pang; L A Kurjanczyk; J L Penner; A P Moran
Journal:  Eur J Biochem       Date:  1993-05-01

6.  Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide.

Authors:  G O Aspinall; C M Lynch; H Pang; R T Shaver; A P Moran
Journal:  Eur J Biochem       Date:  1995-08-01

7.  Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome.

Authors:  N Yuki; Y Ichihashi; T Taki
Journal:  J Neuroimmunol       Date:  1995-07       Impact factor: 3.478

8.  Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of O antigen chains from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome.

Authors:  G O Aspinall; A G McDonald; H Pang
Journal:  Biochemistry       Date:  1994-01-11       Impact factor: 3.162

9.  Isolation of motile and non-motile insertional mutants of Campylobacter jejuni: the role of motility in adherence and invasion of eukaryotic cells.

Authors:  R Yao; D H Burr; P Doig; T J Trust; H Niu; P Guerry
Journal:  Mol Microbiol       Date:  1994-12       Impact factor: 3.501

Review 10.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more
  48 in total

1.  Campylobacter jejuni translocation across intestinal epithelial cells is facilitated by ganglioside-like lipooligosaccharide structures.

Authors:  Rogier Louwen; Edward E S Nieuwenhuis; Leonie van Marrewijk; Deborah Horst-Kreft; Lilian de Ruiter; Astrid P Heikema; Willem J B van Wamel; Jaap A Wagenaar; Hubert P Endtz; Janneke Samsom; Peter van Baarlen; Anna Akhmanova; Alex van Belkum
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 2.  Clinical relevance of infections with zoonotic and human oral species of Campylobacter.

Authors:  Soomin Lee; Jeeyeon Lee; Jimyeong Ha; Yukyung Choi; Sejeong Kim; Heeyoung Lee; Yohan Yoon; Kyoung-Hee Choi
Journal:  J Microbiol       Date:  2016-06-28       Impact factor: 3.422

3.  Structural and kinetic analysis of substrate binding to the sialyltransferase Cst-II from Campylobacter jejuni.

Authors:  Ho Jun Lee; Luke L Lairson; Jamie R Rich; Emilie Lameignere; Warren W Wakarchuk; Stephen G Withers; Natalie C J Strynadka
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

Review 4.  The role of CRISPR-Cas systems in virulence of pathogenic bacteria.

Authors:  Rogier Louwen; Raymond H J Staals; Hubert P Endtz; Peter van Baarlen; John van der Oost
Journal:  Microbiol Mol Biol Rev       Date:  2014-03       Impact factor: 11.056

Review 5.  Campylobacter bacteremia: a rare and under-reported event?

Authors:  R Louwen; P van Baarlen; A H M van Vliet; A van Belkum; J P Hays; H P Endtz
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-03-17

6.  Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides.

Authors:  Astrid P Heikema; Mathijs P Bergman; Hannah Richards; Paul R Crocker; Michel Gilbert; Janneke N Samsom; Willem J B van Wamel; Hubert P Endtz; Alex van Belkum
Journal:  Infect Immun       Date:  2010-04-26       Impact factor: 3.441

7.  Campylobacter jejuni lipooligosaccharide sialylation, phosphorylation, and amide/ester linkage modifications fine-tune human Toll-like receptor 4 activation.

Authors:  Holly N Stephenson; Constance M John; Neveda Naz; Ozan Gundogdu; Nick Dorrell; Brendan W Wren; Gary A Jarvis; Mona Bajaj-Elliott
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

8.  Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections.

Authors:  Soraya Mousavi; Stefan Bereswill; Markus M Heimesaat
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

9.  Antimicrobial and Virulence-Modulating Effects of Clove Essential Oil on the Foodborne Pathogen Campylobacter jejuni.

Authors:  Judit K Kovács; Péter Felső; Lilla Makszin; Zoltán Pápai; Györgyi Horváth; Hajnalka Ábrahám; Tamás Palkovics; Andrea Böszörményi; Levente Emődy; György Schneider
Journal:  Appl Environ Microbiol       Date:  2016-09-30       Impact factor: 4.792

10.  Enhanced, sialoadhesin-dependent uptake of Guillain-Barre syndrome-associated Campylobacter jejuni strains by human macrophages.

Authors:  Astrid P Heikema; Roman I Koning; Sharon Duarte dos Santos Rico; Hans Rempel; Bart C Jacobs; Hubert P Endtz; Willem J B van Wamel; Janneke N Samsom
Journal:  Infect Immun       Date:  2013-03-25       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.